The mechanism of action of low dose methotrexate in rheumatoid arthritis has not been established. It has been shown to have an anti-inflammatory effect and to inhibit neutrophil chemotaxis, but the effect on monocytes has not been widely studied.
The mechanism of action of low dose methotrexate in rheumatoid arthritis has not been defined. Initial studies failed to prove an immune modulating effect,"3 but subsequent studies reported suppression of B cell function,4 delayed type hypersensitivity,5 IgM rheumatoid factor synthesis,6 7 and mononuclear cell proliferation. 7 The effects of methotrexate on monocyte function have not been studied in detail. We studied in vitro the effects of methotrexate on isolated normal donor blood monocytes and the modulation of these effects by folinic acid and by the methyl donor S-adenosylmethionine.
Methods

SEPARATION OF MONONUCLEAR CELLS
Blood (30 ml) from healthy donors was diluted in 50 ml normal saline, layered over 12 ml Ficoll-Hypaque, and separated by centrifugation at 1200 rpm, room temperature, for 30 minutes. Mononuclear cells were collected and washed with RPMI-1640 (Sigma, St Louis, MO), medium-199 (BBL, Cockeysville, MD), or RPMI-1640 medium deficient, supplemented with L-glutamine (2 mmol/l), L-leucine (0 4 mmol/l), L-lysine (0-2 mmol/1), and Lmethionine (0-03 or 0106 mmol/l) (all from Sigma). Superoxide production 58 (7) 64 (8) 35 (7) 
Effect of spermidine
To determine whether the effect of S-adenosylmethionine is mediated through increased synthesis of polyamines we incubated the cells with spermidine at 10-8 to 10-4 mol/l for one hour before the chemotaxis and superoxide production assays. As spermidine can be oxidised to aldehydes and hydrogen peroxide, catalase was added to some of the cultures at 1000 U/ml. Spermidine had no significant effect at any of the concentrations tested (tables 4 and 5).
Discussion
These results showed that methotrexate in concentrations up to 10-5 mol/l did not change random migration of normal peripheral blood This question of relevancy of the in vitro data to the in vivo situation might have been answered by an ex vivo study performed on monocytes of patients with rheumatoid arthritis treated with methotrexate alone. As the current recommended treatment for rheumatoid arthritis requires a combination of drugs, however, starting and maintaining patients with methotrexate alone for the sole purpose of this study was not feasible.
The inhibitory effects of methotrexate were reversed by addition of folinic acid, suggesting that inhibition of chemotaxis and superoxide production is mediated through inhibition of generation of reduced folates.
The methotrexate inhibitory effects were augmented by incubation in culture medium containg a low methionine concentration.
This was reversed by addition of methionine and also by S-adenosylmethionine, and was dependent on concentration. The ability of Sadenosylmethionine to enter cells has been questioned because of its polarity. A recent study, however, reported doubling of Sadenosylmethionine content in L1210 cells incubated with 5 x I0-' M S-adenosylmethionine.22 To evaluate whether the protective effect of S-adenosylmethionine is mediated through generation of polyamines we added spermidine to the cultures after the incubation with methotrexate. In contrast with S-adenosylmethionine, spermidine did not reverse the methotrexate effects on monocytes. Although polyamines (especially in high concentrations. IO-4 mol/l) can modulate leucocyte responses to stimuli,2325 we found no such effect with the concentrations tested. These combined data suggest that methotrexate may also inhibit methylation reactions dependent on S-adenosylmethionine.
Methylation -reactions may have a role in the chemotactic and oxidative responses of monocytes.228 Generation of certain methyl donors might be affected by methotrexate. It primarily inhibits the generation ofreduced folates through inhibition of dihydrofolate reductase,29 and it may secondarily inhibit the synthesis of Sadenosylmethionine. S-adenosylmethionine is synthesised from methionine. In the cell methionine is regenerated from homocysteine, a reaction which requires both methionine synthase, methyl cobalamine, and methyl tetrahydrofolate, which is dependent on dihydrofolate reductase.' In addition to interference with intracellular methionine synthesis, methotrexate may also inhibit methionine transport into the cell.3 ' We are not aware of any report on the effect of methotrexate on S-adenosylmethionine synthesis, but additional indirect evidence suggests such an effect. Rats given nitrous oxide, which inhibits regeneration of methionine through inhibition of methylcobalamine and methionine synthase, had lower tissue concentrations of both methionine and S-adenosylmethionine. 32 In this context it is of interest to note that nitrous oxide was reported to augment methotrexate toxicity in vivo3 and to decrease neutrophil chemotaxis.M Furthermore, after methotrexate treatment patients had increased plasma and urine homocysteine concentrations" and decreased plasma methionine,3 suggesting inhibition of methionine synthesis.
These data support the hypothesis that methotrexate has anti-inflammatory effects.8'0
We suggest that by inhibiting formation of methyl donors, such as reduced folates and, possibly, S-adenosylmethionine, methotrexate may inhibit methylation dependent processes that are essential for the inflammatory response. 
